# A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

Study · id `cardio:ct-nct03344653` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03344653](<https://clinicaltrials.gov/study/NCT03344653>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03344653

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2000 participants.

## Technical summary

Registry record NCT03344653. Randomized; single masking; primary purpose treatment. Start 2017-11-02 (actual); primary completion 2018-09-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 2000 participants (enrolled count; ClinicalTrials.gov record NCT03344653, source copy `cardio:ctgov-nct03344653-2020-12-02`, retrieved 2026-10-26)
- Started: 2017-11-02 (actual) (ClinicalTrials.gov record NCT03344653, source copy `cardio:ctgov-nct03344653-2020-12-02`, retrieved 2026-10-26)
- Primary completion: 2018-09-27 (actual) (ClinicalTrials.gov record NCT03344653, source copy `cardio:ctgov-nct03344653-2020-12-02`, retrieved 2026-10-26)
- Completion: 2020-10-09 (actual) (ClinicalTrials.gov record NCT03344653, source copy `cardio:ctgov-nct03344653-2020-12-02`, retrieved 2026-10-26)
- Countries: Australia; Austria; Belgium; Bulgaria; France; Hong Kong SAR China; Ireland; Italy; Latvia; Lithuania; Malaysia; Netherlands; New Zealand; Norway; Poland; Singapore; Slovakia; South Korea; Spain; Sweden; Switzerland; Thailand; United Kingdom (ClinicalTrials.gov record NCT03344653, source copy `cardio:ctgov-nct03344653-2020-12-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03344653-2020-12-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients
- Acronym: Onyx ONE
- Condition: Coronary Artery Disease
- Intervention (Device): Medtronic Resolute Onyx Zotarolimus-Eluting Coronary Stent System
- Intervention (Device): Biosensors BioFreedom BA9 Drug Coated Coronary Stent
- Lead sponsor: Medtronic Vascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Medtronic Vascular (`cardio:org-medtronic-vascular`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk (`cardio:pubmed-32050061`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE (`cardio:pubmed-35680195`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9094cd0d8d30a9bb97d3850acd502e3ee8d1660cba275f6e0d1400826bcc86ee
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
